Oscar Health Inc. (OSCR) Stock: Identifying Value and Future Vision

Currently, Oscar Health Inc. [OSCR] is trading at $5.06, down -5.77%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The OSCR shares have lost -15.53% over the last week, with a monthly amount drifted -27.71%, and not seem to be holding up well over a long-time horizon.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


On 15, August 2022, Cigna + Oscar Expands Footprint to Bring Small Businesses in Philadelphia Access to Cost-Effective Health Plans. In a post published today on Yahoo Finance, Cigna + Oscar will offer small businesses access to affordable, member-first health insurance products in Bucks, Chester, Delaware, Montgomery, and Philadelphia counties.1.

From an analyst’s perspective:

Oscar Health Inc. [NYSE: OSCR] stock has seen the most recent analyst activity on June 15, 2022, when BofA Securities downgraded its rating to a Underperform and also revised its price target to $4.50 from $6. Previously, BofA Securities downgraded its rating to Neutral on May 26, 2022, and dropped its price target to $6. On February 14, 2022, downgrade downgraded it’s rating to Sell and revised its price target to $9 on the stock. Wells Fargo downgraded its rating to a Equal Weight and decreased its price target to $9 on January 06, 2022. Goldman initiated its recommendation with a Sell and recommended $6.50 as its price target on December 14, 2021. Cowen started tracking with a Market Perform rating for this stock on September 10, 2021, and assigned it a price target of $15. In a note dated March 30, 2021, Wells Fargo initiated an Overweight rating and iterated a target price of $37 on this stock.

This stock has fluctuated between a low of $3.89 and a high of $18.89 over the last 52 weeks. Oscar Health Inc. [NYSE: OSCR] shares were valued at $5.06 at the most recent close of the market.

Analyzing the OSCR fundamentals

Recent quarter sales for Oscar Health Inc. [NYSE:OSCR] were 1.02 billion which represents 92.20% growth.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.94 points at the first support level, and at 4.83 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.26, and for the 2nd resistance point, it is at 5.47.

Oscar Health Inc. [OSCR] reported earnings per share of -$0.36 for its fiscal quarter that ended on 3/30/2022. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.21/share, meaning a difference of $-0.15 and a surprise factor of -71.40%. By comparison, the stated earnings for the previous quarter ended on 12/30/2021 were -$0.95 per share as compared to estimates of -$0.96 per share, a difference of $0.01 representing a surprise of 1.00%.

Transactions by insiders

In the past 3 months, 0 insiders have purchased 0 shares, and 0 have sold 0 shares. Recent insider trading involved Quane Alessandrea C., EVP, Chief Insurance Officer, that happened on Sep 06 when 17532.0 shares were sold. Chief Financial Officer, Blackley Richard Scott completed a deal on Sep 06 to sell 31615.0 shares. Meanwhile, EVP & Chief Legal Officer Bopitiya Ranmali sold 6167.0 shares on Sep 02.